Note: Ingredients listed on restricted chemical lists
EC/CAS
201-174-2/79-07-2
Name of the chemical
2-Chloracetamid
Concentration
≥0.1
EC/CAS
205-634-3/144-62-7
Name of the chemical
oxalic acid
Concentration
≥1
General Information
Revision date
2025-02-25
Product name
Complement Factor D, Human, ELISA kit
1.2.1 Relevant identified uses
For research use only. Not for use in or on humans and animals or for diagnostics
Manufacturer Name
Hycult Biotech
Icons in SDS
Company Information
company name
Hycult Biotech
e-mail address of the competent person responsible for the Safety Data Sheet
info@hycultbiotech.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H302, H312, H318
Hazard statements
Code
Statements
H302
Harmful if swallowed
Section 2
SECTION 2: Hazards identification
OSHA The following hazard Classification and Label elements are attributable to the Stop Solution, which
Contains
2% Oxalic Acid. The ingredients present in the buffers, standards and detection antibody are in an amount that does not require labeling accordance with EC directives or respective national laws. Classification of the substance or mixture
Signal word
Danger
Hazard statements
H302: Harmful if swallowed H312: Harmful in contact with skin H318: Causes serious eye damage.
Precautionary statements
P305 + P351 + P338; IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
Supplemental label elements
none
2.3 Other hazards
The standard is from human origin, which is collected from donors in an FDA-approved collection center. Each unit is tested for the standard FDA-required viral markers, and found negative using FDA-approved methods. While every measure is taken to ensure the safety of our products, we recommend following
ECOLOGICAL INFORMATION
This substance/mixture contains no components classified as persistent, bioaccumulative, and toxic (PBT) or very persistent and very bioaccumulative (vPvB) at concentrations of 0.1% or higher. Additionally, it does not contain components with endocrine-disrupting properties as defined by REACH Article 57(f) at levels of 0.1% or higher.
TOXICOLOGICAL INFORMATION
The substance/mixture does not contain components with endocrine-disrupting properties as defined by REACH Article 57(f) at concentrations of 0.1% or higher.
2.1 Classification of the substance or mixture
Classification according to Regulation (EC) No 1272/2008 Acute toxicity, Oral (Category 4): H302: Harmful if swallowed. Acute toxicity, Dermal (Category 4), H312: Harmful in contact with skin. Serious eye damage (Category 1), H318: Harmful if swallowed or in contact with skin.
